NASDAQ:PLXS - Plexus Stock Price, Forecast & News

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus announced that its Board of Directors has authorized a share repurchase program on Wednesday, February 21st 2018, which permits the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback programs are often a sign that the company's leadership believes its stock is undervalued.

Plexus Corp. (NASDAQ:PLXS) announced its quarterly earnings results on Wednesday, January, 22nd. The technology company reported $1.00 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.93 by $0.07. The technology company earned $852.40 million during the quarter, compared to analysts' expectations of $803.38 million. The company's revenue for the quarter was up 11.4% on a year-over-year basis. During the same period last year, the firm posted $0.91 earnings per share. View Plexus' Earnings History.

Plexus is scheduled to release their next quarterly earnings announcement on Wednesday, April 15th 2020. View Earnings Estimates for Plexus.

Plexus updated its second quarter earnings guidance on Wednesday, January, 22nd. The company provided earnings per share (EPS) guidance of $0.80-0.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.96. The company issued revenue guidance of $790-830 million, compared to the consensus revenue estimate of $821.36 million.

2 brokers have issued 1 year target prices for Plexus' stock. Their forecasts range from $83.00 to $88.00. On average, they expect Plexus' stock price to reach $85.50 in the next twelve months. This suggests a possible upside of 16.7% from the stock's current price. View Analyst Price Targets for Plexus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Plexus.

Media stories about PLXS stock have trended extremely negative this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Plexus earned a news sentiment score of -5.0 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Plexus.

Plexus saw a decline in short interest in January. As of January 31st, there was short interest totalling 921,600 shares, a decline of 7.8% from the January 15th total of 1,000,000 shares. Based on an average daily volume of 202,600 shares, the days-to-cover ratio is presently 4.5 days. Approximately 3.2% of the shares of the stock are short sold. View Plexus' Current Options Chain.

Some companies that are related to Plexus include Benchmark Electronics (BHE), CTS (CTS), Fabrinet (FN), IPG Photonics (IPGP), Jabil (JBL), KEMET (KEM), Key Tronic (KTCC), Mercury Systems (MRCY), Methode Electronics (MEI), Neonode (NEON), Park Electrochemical (PKE), Sanmina (SANM), Trimble (TRMB) and TTM Technologies (TTMI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Walgreens Boots Alliance (WBA), Cisco Systems (CSCO), Berry Global Group (BERY), Intel (INTC), QUALCOMM (QCOM), salesforce.com (CRM), Pfizer (PFE), Twitter (TWTR) and First Solar (FSLR).

Plexus' stock is owned by many different of retail and institutional investors. Top institutional investors include Franklin Resources Inc. (4.59%), State Street Corp (3.05%), Massachusetts Financial Services Co. MA (2.11%), Victory Capital Management Inc. (2.10%), Victory Capital Management Inc. (2.08%) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.84%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View Institutional Ownership Trends for Plexus.

PLXS stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Thrivent Financial for Lutherans, Massachusetts Financial Services Co. MA, Hotchkis & Wiley Capital Management LLC, State Street Corp, Tocqueville Asset Management L.P., Arizona State Retirement System and Public Sector Pension Investment Board. Company insiders that have sold Plexus company stock in the last year include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View Insider Buying and Selling for Plexus.

PLXS stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Marshall Wace LLP, Renaissance Technologies LLC, Mackay Shields LLC, Great West Life Assurance Co. Can, Acadian Asset Management LLC and Oxford Asset Management LLP. View Insider Buying and Selling for Plexus.

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PLXS stock can currently be purchased for approximately $73.27.